\BOOKMARK [0][-]{Abstract.0}{Abstract}{}% 1
\BOOKMARK [0][-]{Contents.0}{Contents}{}% 2
\BOOKMARK [0][-]{Dedication.0}{Dedication}{}% 3
\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 4
\BOOKMARK [1][-]{section.1.1}{Cholinergic\040Systems}{chapter.1}% 5
\BOOKMARK [1][-]{section.1.2}{Cholinergic\040Aspects\040of\040Physiology\040and\040Disease}{chapter.1}% 6
\BOOKMARK [2][-]{subsection.1.2.1}{Alzheimer's\040Disease}{section.1.2}% 7
\BOOKMARK [2][-]{subsection.1.2.2}{Schizophrenia\040and\040Bipolar\040Disorder}{section.1.2}% 8
\BOOKMARK [2][-]{subsection.1.2.3}{Immunity}{section.1.2}% 9
\BOOKMARK [2][-]{subsection.1.2.4}{Neuroinflammation}{section.1.2}% 10
\BOOKMARK [2][-]{subsection.1.2.5}{Stroke}{section.1.2}% 11
\BOOKMARK [2][-]{subsection.1.2.6}{Circadian\040Aspects\040of\040Cholinergic\040Systems}{section.1.2}% 12
\BOOKMARK [2][-]{subsection.1.2.7}{Neurokines}{section.1.2}% 13
\BOOKMARK [1][-]{section.1.3}{Transcriptional\040Connectomics}{chapter.1}% 14
\BOOKMARK [2][-]{subsection.1.3.1}{Transcription\040Factors}{section.1.3}% 15
\BOOKMARK [2][-]{subsection.1.3.2}{microRNAs}{section.1.3}% 16
\BOOKMARK [2][-]{subsection.1.3.3}{Transfer\040RNA\040Fragments}{section.1.3}% 17
\BOOKMARK [1][-]{section.1.4}{Nested\040Multimodal\040Transcriptional\040Interactions\040-\040The\040Need\040for\040Connectomics}{chapter.1}% 18
\BOOKMARK [0][-]{chapter.2}{miRNeo:\040Creation\040of\040a\040Comprehensive\040Connectomics\040Database}{}% 19
\BOOKMARK [1][-]{section.2.1}{Implementation}{chapter.2}% 20
\BOOKMARK [2][-]{subsection.2.1.1}{Neo4j:\040A\040Graph-Based\040Infrastructure}{section.2.1}% 21
\BOOKMARK [2][-]{subsection.2.1.2}{High-throughput\040Database\040Generation}{section.2.1}% 22
\BOOKMARK [2][-]{subsection.2.1.3}{Maintenance\040and\040Quality\040Control}{section.2.1}% 23
\BOOKMARK [1][-]{section.2.2}{Materials}{chapter.2}% 24
\BOOKMARK [2][-]{subsection.2.2.1}{Gene\040Annotation}{section.2.2}% 25
\BOOKMARK [2][-]{subsection.2.2.2}{microRNA\040Annotation}{section.2.2}% 26
\BOOKMARK [2][-]{subsection.2.2.3}{Transcription\040Factor\040Targeting}{section.2.2}% 27
\BOOKMARK [2][-]{subsection.2.2.4}{microRNA\040Interactions}{section.2.2}% 28
\BOOKMARK [2][-]{subsection.2.2.5}{Filtering\040of\040Aggregated\040Prediction\040Scores}{section.2.2}% 29
\BOOKMARK [2][-]{subsection.2.2.6}{De-novo\040Prediction\040of\040tRF\040Targeting}{section.2.2}% 30
\BOOKMARK [2][-]{subsection.2.2.7}{microRNA\040Primate\040Specificity}{section.2.2}% 31
\BOOKMARK [1][-]{section.2.3}{miRNeo\040Usage}{chapter.2}% 32
\BOOKMARK [1][-]{section.2.4}{Statistical\040Approach\040to\040Transcriptional\040Connectomics}{chapter.2}% 33
\BOOKMARK [2][-]{subsection.2.4.1}{Permutation}{section.2.4}% 34
\BOOKMARK [2][-]{subsection.2.4.2}{Gene\040Set\040Enrichment\040Analysis}{section.2.4}% 35
\BOOKMARK [0][-]{chapter.3}{microRNA\040Dynamics\040in\040Cholinergic\040Differentiation\040of\040Human\040Neuronal\040Cells}{}% 36
\BOOKMARK [1][-]{section.3.1}{Neuronal\040Transcriptomes\040-\040Background}{chapter.3}% 37
\BOOKMARK [1][-]{section.3.2}{Cortical\040Single-Cell\040RNA\040Sequencing}{chapter.3}% 38
\BOOKMARK [1][-]{section.3.3}{microRNA\040and\040Transcription\040Factor\040Targeting\040Predictions}{chapter.3}% 39
\BOOKMARK [1][-]{section.3.4}{Gene\040Clustering\040Based\040On\040Expression}{chapter.3}% 40
\BOOKMARK [2][-]{subsection.3.4.1}{Co-Expression\040of\040Functional\040Groups\040of\040Cholinergic\040Genes}{section.3.4}% 41
\BOOKMARK [1][-]{section.3.5}{The\040Cellular\040Model}{chapter.3}% 42
\BOOKMARK [2][-]{subsection.3.5.1}{The\040SH-SY5Y\040Neuroblastoma\040Cell\040Line}{section.3.5}% 43
\BOOKMARK [2][-]{subsection.3.5.2}{The\040LA-N\040Neuroblastoma\040Cell\040Lines}{section.3.5}% 44
\BOOKMARK [2][-]{subsection.3.5.3}{Culture}{section.3.5}% 45
\BOOKMARK [2][-]{subsection.3.5.4}{Differentiation}{section.3.5}% 46
\BOOKMARK [2][-]{subsection.3.5.5}{RNA\040Isolation}{section.3.5}% 47
\BOOKMARK [1][-]{section.3.6}{Small\040RNA\040Sequencing\040and\040Differential\040Expression\040Analysis}{chapter.3}% 48
\BOOKMARK [2][-]{subsection.3.6.1}{Sequencing}{section.3.6}% 49
\BOOKMARK [2][-]{subsection.3.6.2}{Sequence\040Alignment}{section.3.6}% 50
\BOOKMARK [2][-]{subsection.3.6.3}{Differential\040Expression\040Analysis\040-\040R/DESeq2}{section.3.6}% 51
\BOOKMARK [2][-]{subsection.3.6.4}{microRNA\040Dynamics\040in\040CNTF-mediated\040Cholinergic\040Differentiation\040of\040LA-N-2\040and\040LA-N-5}{section.3.6}% 52
\BOOKMARK [2][-]{subsection.3.6.5}{microRNA\040Family\040Enrichment}{section.3.6}% 53
\BOOKMARK [1][-]{section.3.7}{microRNA\040Family\040Gene\040Ontology\040Enrichment}{chapter.3}% 54
\BOOKMARK [2][-]{subsection.3.7.1}{Creation\040of\040miRNA\040Family\040Gene\040Target\040Sets}{section.3.7}% 55
\BOOKMARK [2][-]{subsection.3.7.2}{GO\040Analysis\040of\040Target\040Sets}{section.3.7}% 56
\BOOKMARK [2][-]{subsection.3.7.3}{Large\040Scale\040GO\040Term\040Curation}{section.3.7}% 57
\BOOKMARK [1][-]{section.3.8}{Whole\040Genome\040miRNAGene\040Network\040Generation}{chapter.3}% 58
\BOOKMARK [1][-]{section.3.9}{Application\040to\040Schizophrenia\040and\040Bipolar\040Disorder}{chapter.3}% 59
\BOOKMARK [2][-]{subsection.3.9.1}{Analysed\040Datasets}{section.3.9}% 60
\BOOKMARK [2][-]{subsection.3.9.2}{Microarray\040Quality\040Control\040and\040Data\040Preparation}{section.3.9}% 61
\BOOKMARK [2][-]{subsection.3.9.3}{Differential\040Expression\040Meta-Analysis}{section.3.9}% 62
\BOOKMARK [2][-]{subsection.3.9.4}{Sexual\040Dimorphism\040in\040Schizophrenia\040and\040Bipolar\040Disorder}{section.3.9}% 63
\BOOKMARK [2][-]{subsection.3.9.5}{Combination\040of\040Disease\040Data\040and\040Cell\040Culture}{section.3.9}% 64
\BOOKMARK [2][-]{subsection.3.9.6}{miR-125b-5p\040Acetylcholinesterase\040Targeting\040Assays}{section.3.9}% 65
\BOOKMARK [2][-]{subsection.3.9.7}{hsa-miR-125b-5p\040Targets\040Acetylcholinesterase}{section.3.9}% 66
\BOOKMARK [2][-]{subsection.3.9.8}{Cholinergic/Neurokine\040Mechanisms\040in\040Web-Available\040RNA\040Sequencing\040Experiments}{section.3.9}% 67
\BOOKMARK [0][-]{chapter.4}{Dynamics\040Between\040Small\040and\040Large\040RNA\040in\040the\040Blood\040of\040Stroke\040Victims}{}% 68
\BOOKMARK [1][-]{section.4.1}{RNA\040Sequencing,\040Differential\040Expression,\040and\040Descriptive\040Methods}{chapter.4}% 69
\BOOKMARK [2][-]{subsection.4.1.1}{The\040PREDICT\040Cohort}{section.4.1}% 70
\BOOKMARK [2][-]{subsection.4.1.2}{Clinical\040Parameters\040Collected\040in\040the\040PREDICT\040Study}{section.4.1}% 71
\BOOKMARK [2][-]{subsection.4.1.3}{Sample\040Collection,\040RNA\040Isolation,\040and\040Sequencing}{section.4.1}% 72
\BOOKMARK [2][-]{subsection.4.1.4}{RNA\040Sequencing\040Alignment}{section.4.1}% 73
\BOOKMARK [2][-]{subsection.4.1.5}{Quality\040Control\040and\040Filtering}{section.4.1}% 74
\BOOKMARK [2][-]{subsection.4.1.6}{RNA\040Sequencing\040Differential\040Expression\040Analysis}{section.4.1}% 75
\BOOKMARK [2][-]{subsection.4.1.7}{Gene\040Ontology\040Analyses}{section.4.1}% 76
\BOOKMARK [2][-]{subsection.4.1.8}{Homology\040Computation\040Among\040tRNA\040Fragments}{section.4.1}% 77
\BOOKMARK [2][-]{subsection.4.1.9}{t-Distributed\040Stochastic\040Neighbour\040Embedding}{section.4.1}% 78
\BOOKMARK [2][-]{subsection.4.1.10}{Cholinergic\040Association\040of\040Small\040RNA\040Species}{section.4.1}% 79
\BOOKMARK [1][-]{section.4.2}{Descriptive\040Analysis\040of\040RNA\040Dynamics\040in\040Blood\040After\040Stroke}{chapter.4}% 80
\BOOKMARK [2][-]{subsection.4.2.1}{Differential\040Expression\040of\040Large\040RNA}{section.4.2}% 81
\BOOKMARK [2][-]{subsection.4.2.2}{Gene\040Ontology\040Analyses\040of\040Differentially\040Expressed\040Genes}{section.4.2}% 82
\BOOKMARK [2][-]{subsection.4.2.3}{Differential\040Expression\040of\040small\040RNA}{section.4.2}% 83
\BOOKMARK [2][-]{subsection.4.2.4}{Homology\040Among\040tRNA\040Fragments}{section.4.2}% 84
\BOOKMARK [2][-]{subsection.4.2.5}{Cholinergic\040Association\040of\040Small\040RNA\040Species}{section.4.2}% 85
\BOOKMARK [1][-]{section.4.3}{Blood\040Compartments\040of\040Cholinergic\040Systems\040and\040Small\040RNA\040Species}{chapter.4}% 86
\BOOKMARK [2][-]{subsection.4.3.1}{Large\040RNA\040Regulatory\040Circuits\040in\040Tissues\040of\040the\040Blood}{section.4.3}% 87
\BOOKMARK [2][-]{subsection.4.3.2}{An\040Atlas\040of\040Small\040RNA\040Expression\040in\040Cell\040Types\040of\040the\040Blood}{section.4.3}% 88
\BOOKMARK [2][-]{subsection.4.3.3}{Definition\040of\040Presence\040and\040Absence\040of\040Lowly\040Expressed\040smRNA\040Molecules}{section.4.3}% 89
\BOOKMARK [2][-]{subsection.4.3.4}{Large\040RNA\040Expression\040Patterns\040Identify\040Cholinergic\040Systems\040in\040CD14-positive\040Monocytes}{section.4.3}% 90
\BOOKMARK [2][-]{subsection.4.3.5}{Identification\040of\040Functional\040Enrichment\040of\040smRNA\040Expression\040in\040Blood-Borne\040Cells}{section.4.3}% 91
\BOOKMARK [2][-]{subsection.4.3.6}{Expression\040Patterns\040of\040Differentially\040Expressed\040and\040Cholinergic-Associated\040smRNAs}{section.4.3}% 92
\BOOKMARK [1][-]{section.4.4}{Regulatory\040Circuits\040of\040Small\040RNA\040and\040Transcription\040Factors\040in\040CD14-positive\040Monocytes}{chapter.4}% 93
\BOOKMARK [2][-]{subsection.4.4.1}{Comprehensive\040Circuit\040Network\040Creation}{section.4.4}% 94
\BOOKMARK [2][-]{subsection.4.4.2}{Gene\040Ontology\040Analyses\040of\040TFGene\040Networks\040of\040CD14-positive\040Monocytes}{section.4.4}% 95
\BOOKMARK [2][-]{subsection.4.4.3}{Dichotomy\040of\040Small\040RNA\040Targeting\040of\040Transcription\040Factors\040in\040CD14-positive\040Monocytes}{section.4.4}% 96
\BOOKMARK [2][-]{subsection.4.4.4}{Gradual\040Shift\040in\040Control\040Over\040Transcription\040Factors\040by\040miRNAs\040and\040tRFs}{section.4.4}% 97
\BOOKMARK [2][-]{subsection.4.4.5}{Dichotomous\040Transcriptomic\040Footprints\040of\040Transcription\040Factors\040in\040CD14-positive\040Monocytes}{section.4.4}% 98
\BOOKMARK [1][-]{section.4.5}{Feedforward\040Loops\040of\040Small\040and\040Large\040RNA}{chapter.4}% 99
\BOOKMARK [2][-]{subsection.4.5.1}{Feedforward\040Loop\040Creation}{section.4.5}% 100
\BOOKMARK [2][-]{subsection.4.5.2}{Visualisation\040and\040Modularisation}{section.4.5}% 101
\BOOKMARK [2][-]{subsection.4.5.3}{Module-specific\040Functions\040via\040GO\040Analysis}{section.4.5}% 102
\BOOKMARK [2][-]{subsection.4.5.4}{Feedforward\040Loop\040Network\040of\040CD14-positive\040Monocytes}{section.4.5}% 103
\BOOKMARK [0][-]{chapter.5}{Discussion}{}% 104
\BOOKMARK [1][-]{section.5.1}{Methods}{chapter.5}% 105
\BOOKMARK [1][-]{section.5.2}{The\040Cholinergic/Neurokine\040Interface}{chapter.5}% 106
\BOOKMARK [1][-]{section.5.3}{Small\040RNA\040Therapeutics\040and\040Pharmacology}{chapter.5}% 107
\BOOKMARK [0][-]{chapter.6}{Conclusion}{}% 108
\BOOKMARK [0][-]{chapter.6}{Bibliography}{}% 109
\BOOKMARK [0][-]{chapter*.60}{List\040of\040Figures}{}% 110
\BOOKMARK [0][-]{appendix.A}{Transcription\040Factor\040Regulatory\040Circuits\040-\040Tissue\040Types}{}% 111
\BOOKMARK [0][-]{appendix.B}{List\040of\040Primate-Specific\040Homologues\040of\040Human\040microRNAs}{}% 112
\BOOKMARK [0][-]{appendix.C}{microRNA\040Differential\040Expression\040in\040LA-N-2\040and\040LA-N-5}{}% 113
\BOOKMARK [0][-]{appendix.D}{List\040of\040GO\040Terms\040from\040Analysis\040of\040Differentially\040Expressed\040Large\040RNA\040in\040Stroke}{}% 114
\BOOKMARK [0][-]{appendix.E}{Examples\040of\040Presence/Absence\040Definition\040of\040Small\040RNA}{}% 115
